Share Price | RXO, Inc. Stock Analysis & Recommendation

Q: How big is RXO, Inc.?

Market Cap: As of Jun 18, RXO, Inc. has a market capitalization of 2,476.77 million, categorizing it as a Small Cap company.Recent Quarterly Performance: For the latest four quarters, RXO, Inc. reported net sales of 5,070.00 million and a net profit of -301.00 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,612.00 million and total assets of 3,414.00 million.

Q: What does RXO, Inc. do?

Overview:RXO, Inc. operates in the software products industry and is categorized as a small-cap company.Financial Snapshot:Most recent Net Sales: 1,433 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -31 Million (Quarterly Results - Mar 2025) Market cap: USD 2,476.77 Million (Small Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.29 Return on Equity: -13.04% Price to Book: 1.56Contact Details:Registrar Address: Not available.

Q: Is RXO, Inc. overvalued or undervalued?

As of 2 May 2024, RXO, Inc. has moved from a valuation grade of very expensive to risky, indicating a significant shift in its perceived value. The company is currently considered overvalued based on its financial metrics. Key ratios include a Price to Book Value of 1.66, an EV to EBITDA of 25.17, and a ROE of -13.04%, which reflects a loss-making position.In comparison to its peers, RXO, Inc. has a notably high EV to EBITDA ratio compared to ACI Worldwide, Inc., which stands at 13.43, and HashiCorp, Inc., which is at -27.71. This suggests that RXO, Inc. is not only underperforming but also priced higher relative to its earnings potential compared to more attractive peers. Additionally, the company's recent stock performance has been poor, with a year-to-date return of -33.68%, contrasting sharply with the S&P 500's gain of 2.44% during the same period, further reinforcing the notion that RXO, Inc. is overvalued.

Q: Is RXO, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for RXO, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The Bollinger Bands indicate a bullish signal on the weekly chart but a mildly bearish signal on the monthly chart. Moving averages show a mildly bearish trend on the daily timeframe. Dow Theory supports a mildly bullish stance on both weekly and monthly timeframes. In terms of performance, RXO has underperformed the S&P 500 year-to-date, with a return of -26.55% compared to the S&P's 15.47%, and a one-year return of -37.6% against the S&P's 16.90%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.48 M

Shareholding (Dec 2025)

FII

31.03%

Held by 114 FIIs

DII

31.89%

Held by 59 DIIs

Promoter

0.00%

How big is RXO, Inc.?

22-Jun-2025

As of Jun 18, RXO, Inc. has a market capitalization of 2,476.77 million, with net sales of 5,070.00 million and a net profit of -301.00 million over the latest four quarters.

View full answer

What does RXO, Inc. do?

22-Jun-2025

RXO, Inc. is a small-cap company in the software products industry, reporting net sales of $1.433 billion and a net loss of $31 million as of March 2025. It has a market cap of $2.477 billion, with key metrics indicating no earnings per share due to losses and a debt-to-equity ratio of 0.29.

View full answer

Is RXO, Inc. overvalued or undervalued?

25-Jun-2025

As of May 2, 2024, RXO, Inc. is considered overvalued with a risky valuation grade, reflected by a high EV to EBITDA ratio of 25.17, a negative ROE of -13.04%, and a year-to-date stock performance decline of -33.68%, significantly underperforming compared to its peers and the S&P 500.

View full answer

Is RXO, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, RXO, Inc. shows a neutral trend with mixed signals, including a mildly bullish weekly MACD and bearish monthly MACD, while underperforming the S&P 500 with year-to-date returns of -26.55% compared to the S&P's 15.47%.

View full answer

Compare RXO, Inc. with Similar Stocks

Certara, Inc.Envestnet, Inc.Alteryx, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 4,931.24%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.22 times

Positive results in Jun 25

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

USD 1,964 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.30

Return on Equity

-1.82%

Price to Book

1.27

Revenue and Profits:

Net Sales:

1,469 Million

(Quarterly Results - Dec 2025)

Net Profit:

-46 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-6.96%

6 Months

-24.18%

1 Year

-29.25%

2 Years

-32.98%

3 Years

-32.29%

4 Years

0.0%

5 Years

0.0%

RXO, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.20%

EBIT Growth (5y)

-143.47%

EBIT to Interest (avg)

53.34

Debt to EBITDA (avg)

2.22

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

3.01

Tax Ratio

6.52%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4,931.24%

ROE (avg)

3,851.80%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.27

EV to EBIT

-346.25

EV to EBITDA

22.24

EV to Capital Employed

1.21

EV to Sales

0.42

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.35%

ROE (Latest)

-1.82%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 65 Schemes (37.0%)

Foreign Institutions

Held by 114 Foreign Institutions (31.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.38% vs 0.14% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -228.57% vs -55.56% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,469.00",
          "val2": "1,421.00",
          "chgp": "3.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.00",
          "val2": "28.00",
          "chgp": "-32.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.00",
          "val2": "9.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-33.00",
          "val2": "-9.00",
          "chgp": "-266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-46.00",
          "val2": "-14.00",
          "chgp": "-228.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.10%",
          "val2": "1.40%",
          "chgp": "-0.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.20% vs 15.86% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 65.52% vs -7,350.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,742.00",
          "val2": "4,550.00",
          "chgp": "26.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "109.00",
          "val2": "117.00",
          "chgp": "-6.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "35.00",
          "val2": "30.00",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-72.00",
          "val2": "-86.00",
          "chgp": "16.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-100.00",
          "val2": "-290.00",
          "chgp": "65.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.20%",
          "val2": "6.60%",
          "chgp": "-0.78%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,469.00

1,421.00

3.38%

Operating Profit (PBDIT) excl Other Income

19.00

28.00

-32.14%

Interest

9.00

Exceptional Items

-33.00

-9.00

-266.67%

Consolidate Net Profit

-46.00

-14.00

-228.57%

Operating Profit Margin (Excl OI)

-6.10%

1.40%

-0.75%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.38% vs 0.14% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -228.57% vs -55.56% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5,742.00

4,550.00

26.20%

Operating Profit (PBDIT) excl Other Income

109.00

117.00

-6.84%

Interest

35.00

30.00

16.67%

Exceptional Items

-72.00

-86.00

16.28%

Consolidate Net Profit

-100.00

-290.00

65.52%

Operating Profit Margin (Excl OI)

-1.20%

6.60%

-0.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 26.20% vs 15.86% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 65.52% vs -7,350.00% in Dec 2024

All Annual Results

Company CV

About RXO, Inc.

RXO, Inc.

Software Products

No Details Available.

Company Coordinates

No Company Details Available